FirstMark, a division of GenWay Biotech, Inc. focuses on developing and commercializing non-invasive diagnostic and health monitoring tests for unmet clinical needs. The division is the flagship of GenWay Biotech, Inc., representing the company’s dedication to pioneering breakthroughs in the lab that improve patient care. FirstMark strives to provide the medical community with first-time solutions that would not otherwise be available. All FirstMark tests are based on licensed markers that indicate presence of disease when found in the blood. These simple blood tests, at various stages of commercialization and development, include cardiovascular, oncology, metabolic and infectious disease diagnostic tests. These solutions align with our mission to save and change lives through the knowledge gained from our innovations.
About GenWay Biotech, Inc.
GenWay Biotech, is comprised of three divisions. The FirstMark division is focused on the development and commercialization of non-invasive diagnostic and health monitoring tests for unmet clinical needs. GenWay’s catalog products and custom services divisions are focused on protein and antibody solutions. GenWay’s headquarters are located in the heart of San Diego’s biotech community in the Sorrento Valley/Mesa area.